DARE (Dare Bioscience) Other Current Liabilities: $0.01 Mil (As of Mar. 2026)


DARE Dare Bioscience Inc DARE
21 GF Score
Price $2.03
! 4 Warning Signs
View Full Analysis

What is Dare Bioscience Other Current Liabilities?

Dare Bioscience DARE -0.50% 21 Other Current Liabilities is $0.01 Mil as of Mar. 2026. GuruFocus rates DARE with a GF Score™ of 21/100. The stock has 4 warning signs investors should review.

Dare Bioscience's other current liabilities for the quarter that ended in Mar. 2026 was $0.01 Mil.

Dare Bioscience's quarterly other current liabilities increased from Sep. 2025 ($0.01 Mil) to Dec. 2025 ($0.02 Mil) but then declined from Dec. 2025 ($0.02 Mil) to Mar. 2026 ($0.01 Mil).

Dare Bioscience's annual other current liabilities increased from Dec. 2023 ($0.81 Mil) to Dec. 2024 ($0.81 Mil) but then declined from Dec. 2024 ($0.81 Mil) to Dec. 2025 ($0.02 Mil).

Dare Bioscience Other Current Liabilities Related Terms

Dare Bioscience Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Dare Bioscience's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dare Bioscience Other Current Liabilities Chart

Dare Bioscience Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.53 1.72 0.81 0.81 0.02

Dare Bioscience Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.09 0.19 0.01 0.02 0.01
DARE
21GF Score
Dare Bioscience Inc DARE
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Dare Bioscience Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of $0.01 Mil mean?
Dare Bioscience (DARE) has a Other Current Liabilities of $0.01 Mil as of Mar. 2026. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Dare Bioscience.
Is Dare Bioscience's Other Current Liabilities too high?
Dare Bioscience's current Other Current Liabilities is $0.01 Mil. Overall, Dare Bioscience has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Dare Bioscience's Other Current Liabilities compare to ATNM and NNVC?
Dare Bioscience's Other Current Liabilities of $0.01 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Biotechnology company?
A good Other Current Liabilities depends on the Biotechnology industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Dare Bioscience. Dare Bioscience's current Other Current Liabilities is $0.01 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dare Bioscience stock overvalued right now?
Dare Bioscience (DARE) has a current Other Current Liabilities of $0.01 Mil. The current Other Current Liabilities is $0.01 Mil. Dare Bioscience's overall GF Score™ is 21/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Dare Bioscience (DARE), the current Other Current Liabilities is $0.01 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Dare Bioscience Business Description

Address 3655 Nobel Drive, Suite 260, San Diego, CA, USA, 92122
Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.
21GF Score

Get the complete analysis for DARE

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.03
Price